TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Zinc Supplementation Impact on Child Mortality--Nepal
Brief Summary: The purpose of this study is to determine whether daily supplementation of young children in Nepal with either zinc, iron-folic acid, or both can reduce mortality and morbidity. Young children in Nepal have numerous nutritional deficiencies and high rates of morbidity and mortality. Zinc and/or iron supplementation may be a cost-effective method for reducing these risks.


Options:
A: Intervention Type: DRUG; Name: zinc sulphate dietary supplement; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: iron sulphate-folic acid dietary supplement; Assigned to Arm(s): N/A
B: Arm Label: Zinc syrup; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Liquid zinc syrup | Arm Label: Zinc tablet; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Zinc tablet | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Liquid placebo supplement | Intervention Type: DIETARY_SUPPLEMENT; Name: Liquid zinc syrup; Assigned to Arm(s): Zinc syrup | Intervention Type: DIETARY_SUPPLEMENT; Name: Zinc tablet; Assigned to Arm(s): Zinc tablet | Intervention Type: DIETARY_SUPPLEMENT; Name: Liquid placebo supplement; Assigned to Arm(s): Placebo
C: Arm Label: Vitamin B12; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Vitamin B12 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin B12; Assigned to Arm(s): Vitamin B12 | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: a; Type: EXPERIMENTAL; Interventions: Drug: Glutamine | Arm Label: b; Type: EXPERIMENTAL; Interventions: Drug: Vitamin A, Drug: zinc | Arm Label: c; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vitamin A, Drug: zinc | Arm Label: d; Type: PLACEBO_COMPARATOR; Interventions: Drug: glycine | Arm Label: e; Type: PLACEBO_COMPARATOR; Interventions: Drug: Vitamin A, Drug: zinc | Arm Label: f; Type: EXPERIMENTAL; Interventions: Drug: Vitamin A, Drug: zinc | Intervention Type: DRUG; Name: Glutamine; Assigned to Arm(s): a | Intervention Type: DRUG; Name: Vitamin A; Assigned to Arm(s): b, c, e, f | Intervention Type: DRUG; Name: glycine; Assigned to Arm(s): d | Intervention Type: DRUG; Name: zinc; Assigned to Arm(s): b, c, e, f

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Zinc Supplementation Impact on Child Mortality--Nepal
Brief Summary: The purpose of this study is to determine whether daily supplementation of young children in Nepal with either zinc, iron-folic acid, or both can reduce mortality and morbidity. Young children in Nepal have numerous nutritional deficiencies and high rates of morbidity and mortality. Zinc and/or iron supplementation may be a cost-effective method for reducing these risks.


Options:
A: Intervention Type: DRUG; Name: Zinc; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): N/A
B: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Other: Nutritional Counselling and Education | Arm Label: B; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Micronutrient Supplementation without Zinc | Arm Label: C; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Micronutrient Supplementation with Zinc | Intervention Type: DIETARY_SUPPLEMENT; Name: Micronutrient Supplementation without Zinc; Assigned to Arm(s): B | Intervention Type: DIETARY_SUPPLEMENT; Name: Micronutrient Supplementation with Zinc; Assigned to Arm(s): C | Intervention Type: OTHER; Name: Nutritional Counselling and Education; Assigned to Arm(s): A
C: Intervention Type: DRUG; Name: zinc sulphate dietary supplement; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: iron sulphate-folic acid dietary supplement; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: zinc | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: zinc | Intervention Type: DRUG; Name: zinc; Assigned to Arm(s): 1, 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Newborn Antiseptic Washing and Neonatal Mortality-Nepal
Brief Summary: Neonatal mortality and morbidity is common in Nepal and the vast majority of women deliver babies at home without a skilled birth attendant.

The purpose of this project is two-fold: 1) to evaluate whether washing a newborn child with a dilute antiseptic solution soon after birth can reduce mortality in the first 4 weeks of life and 2) to evaluate whether cleaning the umbilical cord and stump with either soap and water or an antiseptic solution for the first few days of life can reduce umbilical cord infections.


Options:
A: Intervention Type: BEHAVIORAL; Name: Newborn Thermal Care Practice; Assigned to Arm(s): N/A
B: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: 4% Chlorhexidine | Arm Label: B; Type: EXPERIMENTAL; Interventions: Other: Hand washing Soap | Arm Label: C; Type: EXPERIMENTAL; Interventions: Drug: 4% Chlorhexidine | Arm Label: D; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: 4% Chlorhexidine; Assigned to Arm(s): A | Intervention Type: OTHER; Name: Hand washing Soap; Assigned to Arm(s): B | Intervention Type: DRUG; Name: 4% Chlorhexidine; Assigned to Arm(s): C
C: Intervention Type: BEHAVIORAL; Name: Newborn skin cleansing with 0.25% chlorhexidine solution; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Cleansing of umbilical cord with soap and water solution; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Cleansing of umbilical cord with 4% chlorhexidine; Assigned to Arm(s): N/A
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: CHX x 7 days | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: chx once | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: dry cord care | Intervention Type: BEHAVIORAL; Name: chx once; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: CHX x 7 days; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: dry cord care; Assigned to Arm(s): 3

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Newborn Antiseptic Washing and Neonatal Mortality-Nepal
Brief Summary: Neonatal mortality and morbidity is common in Nepal and the vast majority of women deliver babies at home without a skilled birth attendant.

The purpose of this project is two-fold: 1) to evaluate whether washing a newborn child with a dilute antiseptic solution soon after birth can reduce mortality in the first 4 weeks of life and 2) to evaluate whether cleaning the umbilical cord and stump with either soap and water or an antiseptic solution for the first few days of life can reduce umbilical cord infections.


Options:
A: Intervention Type: BEHAVIORAL; Name: Newborn skin cleansing with 0.25% chlorhexidine solution; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Cleansing of umbilical cord with soap and water solution; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Cleansing of umbilical cord with 4% chlorhexidine; Assigned to Arm(s): N/A
B: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: 4% Chlorhexidine | Arm Label: B; Type: EXPERIMENTAL; Interventions: Other: Hand washing Soap | Arm Label: C; Type: EXPERIMENTAL; Interventions: Drug: 4% Chlorhexidine | Arm Label: D; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: 4% Chlorhexidine; Assigned to Arm(s): A | Intervention Type: OTHER; Name: Hand washing Soap; Assigned to Arm(s): B | Intervention Type: DRUG; Name: 4% Chlorhexidine; Assigned to Arm(s): C
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: CHX x 7 days | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: chx once | Arm Label: 3; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: dry cord care | Intervention Type: BEHAVIORAL; Name: chx once; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: CHX x 7 days; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: dry cord care; Assigned to Arm(s): 3
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Chlorhexidine, Procedure: Birth canal wipe | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Procedure: sterile water external genital wipe | Intervention Type: DRUG; Name: Chlorhexidine; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: Birth canal wipe; Assigned to Arm(s): 1 | Intervention Type: PROCEDURE; Name: sterile water external genital wipe; Assigned to Arm(s): 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1
Brief Summary: The purpose of this multicenter, double-blind, placebo-controlled study is to evaluate the efficacy and safety of Lenalidomide in adult subjects with Complex Regional Pain Syndrome (CRPS) Type 1.


Options:
A: Arm Label: lenalidomide; Type: EXPERIMENTAL; Interventions: Drug: lenalidomide | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: lenalidomide; Assigned to Arm(s): lenalidomide | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Burst SCS; Type: ACTIVE_COMPARATOR; Interventions: Device: Burst SCS (Abbott Proclaim IPG and single lead Abbott Octrode at level Th9/10) | Arm Label: Sham; Type: SHAM_COMPARATOR; Interventions: Device: Burst SCS (Abbott Proclaim IPG and single lead Abbott Octrode at level Th9/10) | Intervention Type: DEVICE; Name: Burst SCS (Abbott Proclaim IPG and single lead Abbott Octrode at level Th9/10); Assigned to Arm(s): Burst SCS, Sham
C: Arm Label: CMM; Type: OTHER; Interventions: Other: CMM | Arm Label: HF10 + CMM; Type: ACTIVE_COMPARATOR; Interventions: Device: HF10 Therapy, Other: CMM | Intervention Type: DEVICE; Name: HF10 Therapy; Assigned to Arm(s): HF10 + CMM | Intervention Type: OTHER; Name: CMM; Assigned to Arm(s): CMM, HF10 + CMM
D: Arm Label: matched placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: pregabalin; Type: EXPERIMENTAL; Interventions: Drug: pregabalin | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): matched placebo | Intervention Type: DRUG; Name: pregabalin; Assigned to Arm(s): pregabalin

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Collaborative Randomized Phase III Trial: The Timing of Intervention With Androgen Deprivation in Prostate Cancer Patients With Rising PSA
Brief Summary: RATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen deprivation therapy may stop the adrenal glands from making androgens.

PURPOSE: This randomized phase III trial is studying how well androgen deprivation therapy works in treating patients with prostate cancer.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Bicalutamide | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Bicalutamide; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2
B: Intervention Type: DRUG; Name: antiandrogen therapy; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: releasing hormone agonist therapy; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: orchiectomy; Assigned to Arm(s): N/A
C: Arm Label: Treatment 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Flutamide (Eulexin) and Lupron or Zoladex, Radiation: External Beam Radiotherapy | Arm Label: Treatment 2; Type: ACTIVE_COMPARATOR; Interventions: Radiation: External Beam Radiotherapy | Intervention Type: DRUG; Name: Flutamide (Eulexin) and Lupron or Zoladex; Assigned to Arm(s): Treatment 1 | Intervention Type: RADIATION; Name: External Beam Radiotherapy; Assigned to Arm(s): Treatment 1, Treatment 2
D: Arm Label: A; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Bicalutamide | Intervention Type: DRUG; Name: Bicalutamide; Assigned to Arm(s): B | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tai Chi Mind-Body Therapy for Chronic Heart Failure
Brief Summary: The purpose of this study is to determine the effects of a tai chi exercise program on functional capacity and health-related quality of life in patients with chronic heart failure (HF). This study will also examine the way tai chi influences mental, physical, and social functioning.


Options:
A: Intervention Type: BEHAVIORAL; Name: Aerobic endurance exercise training (ergometer); Assigned to Arm(s): N/A
B: Arm Label: Tai Chi; Type: EXPERIMENTAL; Interventions: Behavioral: 12-week Tai Chi Program | Arm Label: Heart Health Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 12-week Education Program | Intervention Type: BEHAVIORAL; Name: 12-week Tai Chi Program; Assigned to Arm(s): Tai Chi | Intervention Type: BEHAVIORAL; Name: 12-week Education Program; Assigned to Arm(s): Heart Health Education
C: Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Supervised Exercise Training Program | Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Supervised Exercise Training Program; Assigned to Arm(s): 2
D: Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Control | Arm Label: Exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise | Intervention Type: BEHAVIORAL; Name: Exercise; Assigned to Arm(s): Exercise | Intervention Type: BEHAVIORAL; Name: Control; Assigned to Arm(s): Control

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tai Chi Mind-Body Therapy for Chronic Heart Failure
Brief Summary: The purpose of this study is to determine the effects of a tai chi exercise program on functional capacity and health-related quality of life in patients with chronic heart failure (HF). This study will also examine the way tai chi influences mental, physical, and social functioning.


Options:
A: Arm Label: Control Group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Motivational support only | Arm Label: Wii Group; Type: EXPERIMENTAL; Interventions: Behavioral: Structured access to a Wii game computer (Wii) | Intervention Type: BEHAVIORAL; Name: Structured access to a Wii game computer (Wii); Assigned to Arm(s): Wii Group | Intervention Type: BEHAVIORAL; Name: Motivational support only; Assigned to Arm(s): Control Group
B: Arm Label: Tai Chi; Type: EXPERIMENTAL; Interventions: Behavioral: 12-week Tai Chi Program | Arm Label: Heart Health Education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: 12-week Education Program | Intervention Type: BEHAVIORAL; Name: 12-week Tai Chi Program; Assigned to Arm(s): Tai Chi | Intervention Type: BEHAVIORAL; Name: 12-week Education Program; Assigned to Arm(s): Heart Health Education
C: Arm Label: Control group (Group A); Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Arm Label: Intervention group (Group B); Type: OTHER; Interventions: Other: Home-based telehealth program, Other: Home-based rehabilitation, Other: Usual care | Intervention Type: OTHER; Name: Home-based telehealth program; Assigned to Arm(s): Intervention group (Group B) | Intervention Type: OTHER; Name: Home-based rehabilitation; Assigned to Arm(s): Intervention group (Group B) | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Control group (Group A), Intervention group (Group B)
D: Arm Label: No intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Arm Label: Active Comparator; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Rehabilitation intervention | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): No intervention | Intervention Type: BEHAVIORAL; Name: Rehabilitation intervention; Assigned to Arm(s): Active Comparator

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of School Based Supervised Asthma Therapy
Brief Summary: 1. Develop a simple school-based intervention using school-based supervised asthma therapy to increase adherence to asthma medication.
2. Implement a school-based internet monitoring system within both the school-based supervised asthma therapy and parent supervised asthma therapy groups to record asthma symptoms, peak flow meter readings, school absences, and usage of rescue medications at school.
3. Randomly assign 250 children from inner-city school systems to either school-based supervised asthma therapy or parental supervised asthma therapy.
4. Compare children assigned to school-based supervised asthma therapy with children assigned to parent supervised asthma therapy, in regards to time-averaged proportion having at least one exacerbation per month, rescue medication use, peak flow meter readings, asthma symptoms, school absences, and asthma self-management knowledge.


Options:
A: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: School-based Care; Type: EXPERIMENTAL; Interventions: Behavioral: School-based Care | Intervention Type: BEHAVIORAL; Name: School-based Care; Assigned to Arm(s): School-based Care
B: Arm Label: Case Group; Type: N/A; Interventions: N/A | Arm Label: Control Group; Type: N/A; Interventions: Other: MyMediHealth access | Intervention Type: OTHER; Name: MyMediHealth access; Assigned to Arm(s): Control Group
C: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: School-based Care; Type: EXPERIMENTAL; Interventions: Behavioral: School-based Care | Intervention Type: BEHAVIORAL; Name: School-based Care; Assigned to Arm(s): School-based Care
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: School-Based Supervised Asthma Therapy | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: School-Based Supervised Asthma Therapy; Assigned to Arm(s): 1

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial
Brief Summary: The purpose of this study is to determine the effects of low-dose aspirin for the primary prevention of vascular events in patients with type 2 diabetes in Japan.


Options:
A: Intervention Type: DEVICE; Name: Renal Artery Stent with Protective Device/Drug; Assigned to Arm(s): N/A
B: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aspirin | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: No aspirin | Intervention Type: DRUG; Name: Aspirin; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: No aspirin; Assigned to Arm(s): 2
C: Arm Label: Aggrenox; Type: EXPERIMENTAL; Interventions: Drug: Aggrenox | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Aggrenox; Assigned to Arm(s): Aggrenox | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: clopidogrel 75 mg/day; Type: ACTIVE_COMPARATOR; Interventions: Drug: Clopidogrel, cilostazol | Arm Label: clopidogrel 150 mg/day; Type: ACTIVE_COMPARATOR; Interventions: Drug: Clopidogrel, cilostazol | Arm Label: adjunctive cilostazol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Clopidogrel, cilostazol | Arm Label: 75mg clopidogrel; Type: ACTIVE_COMPARATOR; Interventions: Drug: Clopidogrel, cilostazol | Intervention Type: DRUG; Name: Clopidogrel, cilostazol; Assigned to Arm(s): 75mg clopidogrel, adjunctive cilostazol, clopidogrel 150 mg/day, clopidogrel 75 mg/day

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Trial to Test the Safety and Efficacy of Two Doses of Aripiprazole in Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Brief Summary: The purpose of this trial is to test the safety and efficacy of two doses of aripiprazole in child and adolescent patients with bipolar I disorder, manic or mixed episode with or without psychotic features.


Options:
A: Arm Label: A1; Type: EXPERIMENTAL; Interventions: Drug: Aripiprazole | Arm Label: A2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Aripiprazole; Assigned to Arm(s): A1 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): A2
B: Arm Label: Aripiprazole; Type: EXPERIMENTAL; Interventions: Drug: Aripiprazole | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Aripiprazole; Assigned to Arm(s): Aripiprazole | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Aripiprazole 10 mg/day Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aripiprazole tablet, 10 mg | Arm Label: Aripiprazole 30 mg/day Group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aripiprazole tablet, 30 mg | Arm Label: Placebo Group; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo tablet | Intervention Type: DRUG; Name: Aripiprazole tablet, 10 mg; Assigned to Arm(s): Aripiprazole 10 mg/day Group | Intervention Type: DRUG; Name: Aripiprazole tablet, 30 mg; Assigned to Arm(s): Aripiprazole 30 mg/day Group | Intervention Type: DRUG; Name: Placebo tablet; Assigned to Arm(s): Placebo Group
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aripiprazole | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aripiprazole | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Aripiprazole; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Aripiprazole; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 3

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III Trial to Test the Safety and Efficacy of Two Doses of Aripiprazole in Child and Adolescent Patients With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features
Brief Summary: The purpose of this trial is to test the safety and efficacy of two doses of aripiprazole in child and adolescent patients with bipolar I disorder, manic or mixed episode with or without psychotic features.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aripiprazole | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Aripiprazole | Arm Label: 3; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Aripiprazole; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Aripiprazole; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 3
B: Intervention Type: DRUG; Name: Fluoxetine; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Psychotherapy; Assigned to Arm(s): N/A
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Attachment-Based Family Therapy | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced Usual Care | Intervention Type: BEHAVIORAL; Name: Attachment-Based Family Therapy; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Enhanced Usual Care; Assigned to Arm(s): 2
D: Arm Label: QPR intervention; Type: EXPERIMENTAL; Interventions: Other: QPR: question, persuade and refer (SEYLE) | Arm Label: Awareness program; Type: EXPERIMENTAL; Interventions: Other: QPR: question, persuade and refer (SEYLE) | Arm Label: ProfScreen; Type: EXPERIMENTAL; Interventions: Other: QPR: question, persuade and refer (SEYLE) | Arm Label: Control group; Type: EXPERIMENTAL; Interventions: Other: QPR: question, persuade and refer (SEYLE) | Intervention Type: OTHER; Name: QPR: question, persuade and refer (SEYLE); Assigned to Arm(s): Awareness program, Control group, ProfScreen, QPR intervention

Answer: A